Home / Spain / Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A.
Short position disclosed on July 24, 2026. CNMV register read on November 3, 2026.
Evolution of the disclosed total
February 22, 2011 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPMorgan Asset Management (UK) Limited | 1.51% | +0.71 pt | July 24, 2026 |
In the United States LABFF (OTC): 6,693 shares sold short on October 15, 2026. FINRA names no fund.
On the other side: the funds that hold Laboratorios Farmaceuticos Rovi, S.A. Titelia
Get the moves on Laboratorios Farmaceuticos Rovi, S.A. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 24, 2026 | JPMorgan Asset Management (UK) Limited | 1.51% | still open |
| July 23, 2026 | JPMorgan Asset Management (UK) Limited | 1.43% | |
| July 22, 2026 | JPMorgan Asset Management (UK) Limited | 1.21% | |
| July 21, 2026 | JPMorgan Asset Management (UK) Limited | 1.04% | |
| July 17, 2026 | JPMorgan Asset Management (UK) Limited | 0.92% | |
| May 8, 2026 | Citadel Advisors LLC | 0.47% | |
| May 7, 2026 | Citadel Advisors LLC | 0.51% | |
| September 16, 2025 | JPMorgan Asset Management (UK) Limited | 0.80% | |
| March 18, 2025 | JPMorgan Asset Management (UK) Limited | 0.60% | |
| March 13, 2025 | JPMorgan Asset Management (UK) Limited | 0.50% | |
| May 22, 2024 | Marshall Wace LLP | 0.49% | |
| February 28, 2024 | Marshall Wace LLP | 0.50% | |
| March 30, 2023 | Voleon Capital Management LP | 0.47% | |
| March 28, 2023 | Voleon Capital Management LP | 0.51% | |
| February 21, 2023 | Voleon Capital Management LP | 0.51% | |
| March 15, 2011 | JPMorgan Asset Management (UK) Limited | 0.60% | |
| February 22, 2011 | JPMorgan Asset Management (UK) Limited | 0.61% |
Download 17 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Spain
- Solaria Energia y Medioambiente, S.A. 8.13% of the capital sold short
- Enagas, S.A. 4.21% of the capital sold short
- Tecnicas Reunidas, S.A. 3.91% of the capital sold short
- Viscofan, S.A. 3.10% of the capital sold short
- Edreams Odigeo, S.A. 3.09% of the capital sold short
- Grifols, S.A. 1.78% of the capital sold short
- Sacyr, S.A. 1.77% of the capital sold short
- Cellnex Telecom, S.A. 1.59% of the capital sold short
- Ence Energia y Celulosa, S.A. 1.37% of the capital sold short
- Amper, S.A. 1.29% of the capital sold short
- Indra Sistemas, S.A. 1.28% of the capital sold short
- Redeia Corporacion, S.A. 1.26% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Laboratorios Farmaceuticos Rovi, S.A., source CNMV, data as at July 24, 2026, https://www.quivad.com/action/laboratorios-farmaceuticos-rovi-s-a
Embed the chart
<iframe src="https://www.quivad.com/embed/action/laboratorios-farmaceuticos-rovi-s-a" width="600" height="280" title="Laboratorios Farmaceuticos Rovi, S.A." loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/laboratorios-farmaceuticos-rovi-s-a"><img src="https://www.quivad.com/action/laboratorios-farmaceuticos-rovi-s-a/badge.svg" alt="QuiVad, Laboratorios Farmaceuticos Rovi, S.A."></a>